12:00 AM
 | 
Mar 12, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Gintuit regulatory update

FDA approved a BLA for Organogenesis' Gintuit (formerly CelTx) to treat mucogingival conditions. The product is indicated for topical application to a surgically created vascular...

Read the full 101 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >